Displaying 1 to 20 of 21 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Allecra Therapeutics Developer of antibiotic treatments designed to combat multi drug-resistant gram-negative bacteria |
19 Apr 2013 | Series A Co-led the round., Active |
||
|
|
AM-Pharma Holding BV |
Netherlands | N/A |
||
|
|
Amakem NV |
Belgium | N/A |
||
|
|
arGEN-X BV Innovation-driven biopharmaceutical company. |
Netherlands | 1 Sep 2009 | Series A |
|
|
|
Argos Therapeutics Inc |
United States | 1 Apr 2012 | Series D |
|
|
|
Argos Therapeutics Inc |
United States | 1 Apr 2008 | Series C |
|
|
|
Biovex Inc Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. |
United States | Series F Active |
||
|
|
Biovex Inc Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. |
United States | Series E Active |
||
|
Bluebird Bio Inc Developer of an innovative gene therapies for severe genetic disorders |
United States | 1 Jul 2012 | Series D |
|
|
|
Bluebird Bio Inc Developer of an innovative gene therapies for severe genetic disorders |
United States | 1 Apr 2011 | Venture |
|
|
|
Bluebird Bio Inc Developer of an innovative gene therapies for severe genetic disorders |
United States | 1 Mar 2010 | Series B |
|
|
|
CircuLite Inc Develops superficially implanted ventricular assist devices. |
Germany | 1 Nov 2011 | Series D |
|
|
|
CircuLite Inc Develops superficially implanted ventricular assist devices. |
Germany | 1 Jan 2010 | Series C |
|
|
|
Mitralign Inc Percutaneous mitral valve repair system. |
United States | Series C |
||
|
|
Mitralign Inc Percutaneous mitral valve repair system. |
United States | 1 May 2012 | Series D |
|
|
|
Pathway Medical Technologies Inc Manufacturer of medical devices for the treatment of arterial disease. |
United States | 1 Mar 2009 | Series D |
|
|
|
Pathway Medical Technologies Inc Manufacturer of medical devices for the treatment of arterial disease. |
United States | 1 Apr 2008 | Series C |
|
|
|
PneumRx Inc Developer of minimally invasive treatments for emphysema patients. |
United States | 1 Jan 2011 | N/A |
|
|
|
Promedior Inc A biotechnology company developing novel biologic therapeutics to treat fibroproliferative diseases. |
United States | 1 Mar 2010 | Series C |
|
|
Santaris Pharma A/S |
Denmark | 1 Jun 2012 | Venture Initial investment. Round participant. Active |